Cargando…
Utility of fractional excretion of urea nitrogen in heart failure patients with chronic kidney disease
AIMS: Maintenance of euvolaemia with diuretics is critical in heart failure (HF) patients with chronic kidney disease (CKD); however, it is challenging because no reliable marker of volume status exists. Fractional excretion of urea nitrogen (FEUN) is a useful index of volume status in patients with...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192260/ https://www.ncbi.nlm.nih.gov/pubmed/36823779 http://dx.doi.org/10.1002/ehf2.14327 |
_version_ | 1785043590321274880 |
---|---|
author | Watanabe, Yukihiro Kubota, Yoshiaki Nishino, Takuya Tara, Shuhei Kato, Katsuhito Hayashi, Daisuke Mozawa, Kosuke Matsuda, Junya Tokita, Yukichi Yasutake, Masahiro Asai, Kuniya Iwasaki, Yu‐ki |
author_facet | Watanabe, Yukihiro Kubota, Yoshiaki Nishino, Takuya Tara, Shuhei Kato, Katsuhito Hayashi, Daisuke Mozawa, Kosuke Matsuda, Junya Tokita, Yukichi Yasutake, Masahiro Asai, Kuniya Iwasaki, Yu‐ki |
author_sort | Watanabe, Yukihiro |
collection | PubMed |
description | AIMS: Maintenance of euvolaemia with diuretics is critical in heart failure (HF) patients with chronic kidney disease (CKD); however, it is challenging because no reliable marker of volume status exists. Fractional excretion of urea nitrogen (FEUN) is a useful index of volume status in patients with renal failure. We aimed to examine whether FEUN is a surrogate marker of volume status for risk stratification in HF patients with CKD. METHODS AND RESULTS: We examined 516 HF patients with CKD (defined as discharge estimated glomerular filtration rate < 60 mL/min/1.73 m(2)) whose FEUN was measured at discharge (median age, 80 years; 58% male). The patients were divided into four groups according to quartile FEUN value at discharge: low‐FEUN, FEUN ≤ 32.1; medium‐FEUN, 32.1 < FEUN ≤ 38.0; high‐FEUN, 38.0 < FEUN ≤ 43.7; and extremely‐high‐FEUN, FEUN > 43.7. FEUN was calculated by the following formula: (urinary urea × serum creatinine) × 100/(serum urea × urinary creatinine). During the 3 year follow‐up, 131 HF readmissions occurred. Kaplan–Meier analysis showed that the HF readmission rate was significantly lower in the medium‐FEUN group than in the other three groups (log‐rank test, P = 0.029). Multivariate Cox regression analysis identified the low‐FEUN, high‐FEUN, and extremely‐high‐FEUN values as independent factors associated with post‐discharge HF readmission. In the analysis of 130 patients who underwent right heart catheterization during hospitalization, a significant correlation between FEUN value and right atrial pressure was observed (R = 0.243, P = 0.005). Multivariate linear regression analysis revealed that FEUN value at discharge decreased in a dose‐dependent manner with loop diuretics. CONCLUSIONS: In HF patients with CKD, FEUN is a potential marker of volume status for risk stratification of post‐discharge HF readmission. Low FEUN value (FEUN ≤ 32.1) may represent intravascular dehydration, whereas high FEUN value (FEUN > 38.0) may represent residual congestion; both of them were independent risk factors for HF readmission. FEUN may be useful to determine euvolaemia and guide fluid management in HF patients with CKD. |
format | Online Article Text |
id | pubmed-10192260 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-101922602023-05-19 Utility of fractional excretion of urea nitrogen in heart failure patients with chronic kidney disease Watanabe, Yukihiro Kubota, Yoshiaki Nishino, Takuya Tara, Shuhei Kato, Katsuhito Hayashi, Daisuke Mozawa, Kosuke Matsuda, Junya Tokita, Yukichi Yasutake, Masahiro Asai, Kuniya Iwasaki, Yu‐ki ESC Heart Fail Original Articles AIMS: Maintenance of euvolaemia with diuretics is critical in heart failure (HF) patients with chronic kidney disease (CKD); however, it is challenging because no reliable marker of volume status exists. Fractional excretion of urea nitrogen (FEUN) is a useful index of volume status in patients with renal failure. We aimed to examine whether FEUN is a surrogate marker of volume status for risk stratification in HF patients with CKD. METHODS AND RESULTS: We examined 516 HF patients with CKD (defined as discharge estimated glomerular filtration rate < 60 mL/min/1.73 m(2)) whose FEUN was measured at discharge (median age, 80 years; 58% male). The patients were divided into four groups according to quartile FEUN value at discharge: low‐FEUN, FEUN ≤ 32.1; medium‐FEUN, 32.1 < FEUN ≤ 38.0; high‐FEUN, 38.0 < FEUN ≤ 43.7; and extremely‐high‐FEUN, FEUN > 43.7. FEUN was calculated by the following formula: (urinary urea × serum creatinine) × 100/(serum urea × urinary creatinine). During the 3 year follow‐up, 131 HF readmissions occurred. Kaplan–Meier analysis showed that the HF readmission rate was significantly lower in the medium‐FEUN group than in the other three groups (log‐rank test, P = 0.029). Multivariate Cox regression analysis identified the low‐FEUN, high‐FEUN, and extremely‐high‐FEUN values as independent factors associated with post‐discharge HF readmission. In the analysis of 130 patients who underwent right heart catheterization during hospitalization, a significant correlation between FEUN value and right atrial pressure was observed (R = 0.243, P = 0.005). Multivariate linear regression analysis revealed that FEUN value at discharge decreased in a dose‐dependent manner with loop diuretics. CONCLUSIONS: In HF patients with CKD, FEUN is a potential marker of volume status for risk stratification of post‐discharge HF readmission. Low FEUN value (FEUN ≤ 32.1) may represent intravascular dehydration, whereas high FEUN value (FEUN > 38.0) may represent residual congestion; both of them were independent risk factors for HF readmission. FEUN may be useful to determine euvolaemia and guide fluid management in HF patients with CKD. John Wiley and Sons Inc. 2023-02-23 /pmc/articles/PMC10192260/ /pubmed/36823779 http://dx.doi.org/10.1002/ehf2.14327 Text en © 2023 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles Watanabe, Yukihiro Kubota, Yoshiaki Nishino, Takuya Tara, Shuhei Kato, Katsuhito Hayashi, Daisuke Mozawa, Kosuke Matsuda, Junya Tokita, Yukichi Yasutake, Masahiro Asai, Kuniya Iwasaki, Yu‐ki Utility of fractional excretion of urea nitrogen in heart failure patients with chronic kidney disease |
title | Utility of fractional excretion of urea nitrogen in heart failure patients with chronic kidney disease |
title_full | Utility of fractional excretion of urea nitrogen in heart failure patients with chronic kidney disease |
title_fullStr | Utility of fractional excretion of urea nitrogen in heart failure patients with chronic kidney disease |
title_full_unstemmed | Utility of fractional excretion of urea nitrogen in heart failure patients with chronic kidney disease |
title_short | Utility of fractional excretion of urea nitrogen in heart failure patients with chronic kidney disease |
title_sort | utility of fractional excretion of urea nitrogen in heart failure patients with chronic kidney disease |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192260/ https://www.ncbi.nlm.nih.gov/pubmed/36823779 http://dx.doi.org/10.1002/ehf2.14327 |
work_keys_str_mv | AT watanabeyukihiro utilityoffractionalexcretionofureanitrogeninheartfailurepatientswithchronickidneydisease AT kubotayoshiaki utilityoffractionalexcretionofureanitrogeninheartfailurepatientswithchronickidneydisease AT nishinotakuya utilityoffractionalexcretionofureanitrogeninheartfailurepatientswithchronickidneydisease AT tarashuhei utilityoffractionalexcretionofureanitrogeninheartfailurepatientswithchronickidneydisease AT katokatsuhito utilityoffractionalexcretionofureanitrogeninheartfailurepatientswithchronickidneydisease AT hayashidaisuke utilityoffractionalexcretionofureanitrogeninheartfailurepatientswithchronickidneydisease AT mozawakosuke utilityoffractionalexcretionofureanitrogeninheartfailurepatientswithchronickidneydisease AT matsudajunya utilityoffractionalexcretionofureanitrogeninheartfailurepatientswithchronickidneydisease AT tokitayukichi utilityoffractionalexcretionofureanitrogeninheartfailurepatientswithchronickidneydisease AT yasutakemasahiro utilityoffractionalexcretionofureanitrogeninheartfailurepatientswithchronickidneydisease AT asaikuniya utilityoffractionalexcretionofureanitrogeninheartfailurepatientswithchronickidneydisease AT iwasakiyuki utilityoffractionalexcretionofureanitrogeninheartfailurepatientswithchronickidneydisease |